Evidence map›Paper›PMID 34235214›Full record

ArticleBioMed research international2021

Variant Analysis of Alkaptonuria Families with Significant Founder Effect in Jordan.

Raida Khalil, Dema Ali, Nesrin Mwafi, Arwa Alsaraireh, Loiy Obeidat, Eman Albsoul, Ibrahim Al Sbou'

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Raida KhalilDepartment of Biotechnology and Genetic Engineering-Faculty of Science, University of Philadelphia, Amman, Jordan.ORCID https://orcid.org/0000-0002-9664-2766
Dema AliCell Therapy Center, The University of Jordan, Amman, Jordan.ORCID https://orcid.org/0000-0002-7185-5028
Nesrin MwafiDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, Mutah University, AlKarak, Jordan.ORCID https://orcid.org/0000-0001-7541-3190
Arwa AlsarairehMaternal and Child Health Nursing Department, Faculty of Nursing, Mutah University, AlKarak, Jordan.ORCID https://orcid.org/0000-0002-7469-4223
Loiy ObeidatDepartment of Biotechnology and Genetic Engineering-Faculty of Science, University of Philadelphia, Amman, Jordan.ORCID https://orcid.org/0000-0001-5734-4355
Eman AlbsoulDepartment of Biotechnology and Genetic Engineering-Faculty of Science, University of Philadelphia, Amman, Jordan.ORCID https://orcid.org/0000-0002-8633-1745
Ibrahim Al Sbou'Medical Laboratory Science, Faculty of science, Mutah University, AlKarak, Jordan.ORCID https://orcid.org/0000-0002-8386-6437
Mutah University · JOPhiladelphia University · JOUniversity of Jordan · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetabolic disorder alkaptonuria is an autosomal recessive disorder caused by mutations in the

methodsWe clinically evaluated 18 alkaptonuria patients (age range, 3 to 60 years) from four unrelated families. Furthermore, 11 out of 18 alkaptonuria patients and 7 unaffected members were enrolled for molecular investigations by utilizing Sanger sequencing to identify variants of the 14 exons of

resultsWe found that the seven patients from the 4 unrelated families carried a recurrent pathogenic missense variant (c.365C>T, p. Ala122Val) in exon 6 of

conclusionIn this study, we confirmed that the most common variants in Jordanian AKU patients was c.365C>T, p. Ala122Val in exon 6 of

Indexed as

Family HealthFounder EffectGenes, RecessiveAdolescentAdultAlkaptonuriaChildChild, PreschoolExonsFemaleGenetic VariationHeterozygoteHomogentisate 1,2-DioxygenaseHomogentisic AcidHumansJordanHomogentisate 1,2-DioxygenaseHomogentisic AcidOligonucleotides

Identifiers

PMID34235214
PMCPMC8216811
OpenAlexW3135381150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.